Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
British Journal of Haematology
|
May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma
Robert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Blood Cancer Journal
|
June 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin
Shin Yeu Ong, Lu Chen, Jomel Meeko Manzano, et al.
Blood Advances
|
May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Natasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Blood
|
December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Alex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Blood
|
April 7, 2021
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results
Ranjana H Advani, Alison J Moskowitz, Nancy L Bartlett, et al.
Blood Advances
|
March 19, 2024
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis
Julia Driessen, Fer de Wit, Alex F Herrera, et al.
British Journal of Haematology
|
January 21, 2010
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging
Craig H Moskowitz, Joachim Yahalom, Andrew D Zelenetz, et al.
Leukemia & Lymphoma
|
March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience
Zachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Cancer
|
April 29, 2014
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project
Kenneth R Carson, Scott D Newsome, Ellen J Kim, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
British Journal of Haematology
|
May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma
Robert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Blood Cancer Journal
|
June 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin
Shin Yeu Ong, Lu Chen, Jomel Meeko Manzano, et al.
Blood Advances
|
May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Natasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Blood
|
December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Alex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Blood
|
April 7, 2021
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results
Ranjana H Advani, Alison J Moskowitz, Nancy L Bartlett, et al.
Blood Advances
|
March 19, 2024
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis
Julia Driessen, Fer de Wit, Alex F Herrera, et al.
British Journal of Haematology
|
January 21, 2010
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging
Craig H Moskowitz, Joachim Yahalom, Andrew D Zelenetz, et al.
Leukemia & Lymphoma
|
March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience
Zachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
Cancer
|
April 29, 2014
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project
Kenneth R Carson, Scott D Newsome, Ellen J Kim, et al.
Page
of 10